Determination of MIC Quality Control Parameters for Exebacase, a Novel Lysin with Antistaphylococcal Activity

Exebacase (CF-301), a novel, antistaphylococcal lysin (cell wall hydrolase) is the first agent of this class to enter late-stage clinical development (phase 3, NCT04160468) for the treatment of Staphylococcus aureus bacteremia, including right-sided endocarditis. A multilaboratory Clinical and Labor...

Descripción completa

Detalles Bibliográficos
Autores principales: Traczewski, Maria M., Ambler, Jane E., Schuch, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Bacteriology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218745/
https://www.ncbi.nlm.nih.gov/pubmed/33910968
http://dx.doi.org/10.1128/JCM.03117-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218745/
https://www.ncbi.nlm.nih.gov/pubmed/33910968
http://dx.doi.org/10.1128/JCM.03117-20

Ejemplares similares